Stryker is recalling its Cartiva toe implant after new studies reveal alarmingly high failure rates which can result in severe pain, additional surgeries and other complications. The warning label for the Cartiva implant indicates the device has a failure rate of 13.5%. However, recently published data indicate premature failure rates as high as 64%.
The legal team at Alex Davis Law Office recently filed one of the first Cartiva lawsuits in the nation. The case is being litigated in Maryland federal court with our partners at Jenner Law. We represent numerous Cartiva toe implant victims all over the country. While patients are experiencing significant nerve damage and debilitating pain, the recalled Cartiva toe implant is also linked to a wide range of complications, including trouble maintaining balance and difficulty walking. In addition, patients are often forced to undergo additional, costly surgeries to correct the problems. The most common remedy is a toe fusion surgery.
Cartiva Implants pulled off hospital shelves
Not only is Stryker recalling the Cartiva device, but the company is also taking the rare step of removing the toe implants from the market. That means healthcare providers are pulling them from their inventory and are no longer implanting them in patients. Healthcare providers are also being instructed to reach out to their patients who have already been implanted with the Cartiva device and to notify them of additional risks linked to the product.
Call us for a free case evaluation
If you or a loved one suffered injuries from a Cartiva toe implant, you may be entitled to financial compensation. To review your case, contact the lawyers at Alex Davis Law or call 502-882-6000 to schedule a free consultation today.